Check out our most popular compounded medications! Get Started
Ergoloid Mesylates 1 mg/mL Oral Solution is a liquid formulation designed for oral administration, providing precise dosing and convenient delivery of medication. This solution is particularly beneficial for patients requiring specific dosage strengths or those who have difficulty swallowing tablets or capsules.
Ergoloid Mesylates is primarily used in the management of symptoms associated with cognitive decline, such as those found in dementia and age-related cognitive impairment. It may help improve mental function, mood, and overall quality of life in affected individuals.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Ergoloid Mesylates 1 mg/mL Oral Solution is a compounded medication formulated to support cognitive function in individuals experiencing age-related cognitive decline. This oral solution provides a convenient and accurate dosing method, especially for patients who may have difficulty swallowing tablets or require a specific dosage strength not commercially available.
This liquid formulation consists of one or more active ingredients dissolved in a suitable solvent, intended for oral administration. It offers precise dosing and convenient delivery of medication, making it an excellent option when tailored dosing or ease of swallowing is required. The solution ensures that patients receive the exact dosage prescribed, enhancing the effectiveness of the treatment.
Ergoloid Mesylates are derived from ergot alkaloids and have been used to manage symptoms associated with decreased mental capacity due to aging or vascular problems. They work by improving blood flow and oxygen delivery to the brain, which may help alleviate symptoms such as memory loss, mood changes, and reduced cognitive function.
For prescribers, compounding Ergoloid Mesylates into a 1 mg/mL oral solution allows for customization of the dosage to meet individual patient needs. This can be particularly beneficial for elderly patients or those with swallowing difficulties who may not tolerate solid dosage forms. The oral solution ensures better compliance and facilitates dose adjustments as necessary.
Patients taking Ergoloid Mesylates Oral Solution should follow their healthcare provider's instructions carefully. It is important to use the measuring device provided to ensure accurate dosing. As with all medications, potential side effects may occur, including gastrointestinal discomfort, dizziness, or headache. Patients should report any adverse effects to their healthcare provider promptly.
Please note that while Ergoloid Mesylates have been used for cognitive support, their effectiveness may vary among individuals. Ongoing assessment by a healthcare professional is essential to determine the appropriateness of this therapy for each patient.
If you have any questions about Ergoloid Mesylates 1 mg/mL Oral Solution or how it may benefit you or your patients, please reach out to us. Our team at Bayview Pharmacy is here to provide support and assist with any inquiries regarding compounded medications.
Ergoloid Mesylates 1 mg/mL Oral Solution is a liquid formulation designed for oral administration, providing precise dosing and ease of use, particularly beneficial for patients who require specific dosage strengths or have difficulty swallowing tablets or capsules. This medication is primarily used in the management of cognitive and mood disorders associated with aging, such as symptoms of dementia and other related conditions. It is important for both patients and prescribers to be aware of potential drug interactions when using this formulation to ensure appropriate treatment.
Ergoloid Mesylates may interact with several types of medications, which can alter its effectiveness or increase the risk of adverse effects. Patients taking antihypertensive drugs should be cautious, as Ergoloid Mesylates can potentiate the effects of these medications, potentially leading to excessive lowering of blood pressure. Regular monitoring of blood pressure is recommended, and dosage adjustments may be necessary.
Concomitant use of Ergoloid Mesylates with other vasodilators or medications that affect blood flow, such as nitrates or calcium channel blockers, may enhance the vasodilatory effects, increasing the risk of hypotension. Patients should be monitored for signs of dizziness or fainting, and prescribers should consider adjusting the dosages of these medications if necessary.
Ergoloid Mesylates may also interact with anticoagulants and antiplatelet agents, such as warfarin or aspirin, potentially increasing the risk of bleeding. Patients should be monitored for signs of bleeding, and regular blood tests may be required to ensure safe use. It is crucial for prescribers to evaluate the risk-benefit ratio when considering the co-administration of these medications.
Additionally, the use of Ergoloid Mesylates with other central nervous system (CNS) stimulants or depressants should be approached with caution. The combination may either enhance or diminish the effects of these agents, leading to increased side effects or reduced therapeutic efficacy. Patients should be advised to report any unusual symptoms or changes in their condition to their healthcare provider promptly.
Patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs, supplements, and herbal products, to avoid potential interactions. Prescribers should conduct a thorough medication review and consider potential interactions when initiating Ergoloid Mesylates therapy.
If you have any questions or concerns about the use of Ergoloid Mesylates 1 mg/mL Oral Solution and its potential interactions with other medications, please reach out to us for further guidance and support.
Ergoloid Mesylates 1 mg/mL Oral Solution is a liquid formulation designed to deliver precise dosing of the active ingredient, ergoloid mesylates, which is a combination of three ergot alkaloids: dihydroergocornine, dihydroergocristine, and dihydroergocryptine. These compounds are known for their ability to modulate neurotransmitter activity in the brain, particularly affecting the dopaminergic, serotonergic, and adrenergic systems. By influencing these pathways, ergoloid mesylates can help improve cognitive function and cerebral metabolism, which may be beneficial in managing symptoms associated with certain cognitive disorders.
The oral solution form of ergoloid mesylates offers several advantages. It allows for accurate dosing, which is crucial for achieving the desired therapeutic effect while minimizing potential side effects. The liquid form is particularly beneficial for patients who have difficulty swallowing tablets or capsules, ensuring that they receive the correct dosage without the discomfort or risk of choking. Additionally, the solution can be easily adjusted to meet specific dosage requirements, providing flexibility in treatment plans tailored to individual patient needs.
Ergoloid mesylates are primarily used in the treatment of cognitive impairment and symptoms associated with age-related cognitive decline. By enhancing blood flow and oxygen utilization in the brain, this medication may help alleviate symptoms such as memory loss, confusion, and reduced mental clarity. It is important to note that while ergoloid mesylates can support cognitive function, they are not a cure for underlying neurodegenerative diseases but may offer symptomatic relief and improve quality of life for patients.
For prescribers, it is essential to consider the patient's overall health status, including any potential contraindications or interactions with other medications the patient may be taking. Monitoring the patient's response to the medication and adjusting the dosage as necessary can help optimize treatment outcomes. Patients should be informed about the potential side effects, which may include gastrointestinal disturbances, dizziness, or headaches, and advised to report any adverse reactions to their healthcare provider.
If you have any questions about Ergoloid Mesylates 1 mg/mL Oral Solution or its use in treating cognitive disorders, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to make informed decisions about your healthcare.
Ergoloid Mesylates 1 mg/mL Oral Solution is a liquid formulation containing ergoloid mesylates as the active ingredient, dissolved in a suitable solvent for oral administration. It is designed to provide accurate dosing and convenient delivery of medication.
Oral solutions offer precise dosing and are easy to swallow, making them ideal for patients who have difficulty swallowing tablets or require a specific dosage strength that is not available in solid form.
Follow your healthcare provider's instructions for taking Ergoloid Mesylates 1 mg/mL Oral Solution. Typically, it is taken by measuring the prescribed dose using a suitable measuring device and swallowing it directly.
Consult your healthcare provider before mixing the oral solution with food or drinks, as it may affect the absorption or effectiveness of the medication.
If you miss a dose of Ergoloid Mesylates 1 mg/mL Oral Solution, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up.
Like all medications, Ergoloid Mesylates 1 mg/mL Oral Solution may cause side effects. Common side effects include dizziness, headache, and gastrointestinal disturbances. Contact your healthcare provider if you experience any severe or persistent side effects.
Store Ergoloid Mesylates 1 mg/mL Oral Solution at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
Before taking Ergoloid Mesylates 1 mg/mL Oral Solution with other medications, consult your healthcare provider to avoid potential interactions that may affect the efficacy or safety of the treatment.
The suitability of Ergoloid Mesylates 1 mg/mL Oral Solution for children depends on the specific medical condition and the healthcare provider's recommendation. Always follow the guidance of a healthcare professional when administering this medication to children.
If you suspect an overdose of Ergoloid Mesylates 1 mg/mL Oral Solution, seek immediate medical attention. Symptoms of overdose may include severe dizziness, confusion, or fainting.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
